These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
785 related articles for article (PubMed ID: 29469940)
21. Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS): a study applying Thyroid Imaging Reporting and Data System (TIRADS). Yoon JH; Kwon HJ; Kim EK; Moon HJ; Kwak JY Clin Endocrinol (Oxf); 2016 Aug; 85(2):275-82. PubMed ID: 26639612 [TBL] [Abstract][Full Text] [Related]
22. PREDICTIVE VALUE OF SOMATIC MUTATIONS FOR THE DEVELOPMENT OF MALIGNANCY IN THYROID NODULES BY CYTOPATHOLOGY. Halászlaki C; Tóbiás B; Balla B; Kósa JP; Horányi J; Bölöny E; Nagy Z; Speer G; Járay B; Székely E; Istók R; Székely T; Putz Z; Dank M; Lakatos P; Takács I Endocr Pract; 2016 Sep; 22(9):1081-7. PubMed ID: 27214302 [TBL] [Abstract][Full Text] [Related]
23. Subclassification of the Bethesda Category III (AUS/FLUS): A study of thyroid FNA cytology based on ThinPrep slides from the National Cancer Center in China. Zhao H; Guo H; Zhao L; Cao J; Sun Y; Wang C; Zhang Z Cancer Cytopathol; 2021 Aug; 129(8):642-648. PubMed ID: 34139103 [TBL] [Abstract][Full Text] [Related]
24. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India. Mahajan S; Srinivasan R; Rajwanshi A; Radotra B; Panda N; Dey P; Gupta N; Nijhawan R Acta Cytol; 2017; 61(2):103-110. PubMed ID: 28407624 [TBL] [Abstract][Full Text] [Related]
25. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines. Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972 [TBL] [Abstract][Full Text] [Related]
26. Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy. Gan TR; Nga ME; Lum JH; Wong WM; Tan WB; Parameswaran R; Ngiam KY Cancer Cytopathol; 2017 Apr; 125(4):245-256. PubMed ID: 28192631 [TBL] [Abstract][Full Text] [Related]
27. Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy. Choi YJ; Baek JH; Ha EJ; Lim HK; Lee JH; Kim JK; Song DE; Shong YK; Hong SJ Thyroid; 2014 Mar; 24(3):494-501. PubMed ID: 23947771 [TBL] [Abstract][Full Text] [Related]
28. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology. Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417 [TBL] [Abstract][Full Text] [Related]
29. Risk stratification of indeterminate thyroid fine-needle aspiration biopsy specimens based on mutation analysis. Filicori F; Keutgen XM; Buitrago D; AlDailami H; Crowley M; Fahey TJ; Zarnegar R Surgery; 2011 Dec; 150(6):1085-91. PubMed ID: 22136825 [TBL] [Abstract][Full Text] [Related]
30. Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance". Ohori NP; Nikiforova MN; Schoedel KE; LeBeau SO; Hodak SP; Seethala RR; Carty SE; Ogilvie JB; Yip L; Nikiforov YE Cancer Cytopathol; 2010 Feb; 118(1):17-23. PubMed ID: 20099311 [TBL] [Abstract][Full Text] [Related]
31. Malignancy risk and characteristics of thyroid nodules with two consecutive results of atypia of undetermined significance or follicular lesion of undetermined significance on cytology. Park VY; Kim EK; Kwak JY; Yoon JH; Moon HJ Eur Radiol; 2015 Sep; 25(9):2601-7. PubMed ID: 25740802 [TBL] [Abstract][Full Text] [Related]
32. Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules. Eszlinger M; Krogdahl A; Münz S; Rehfeld C; Precht Jensen EM; Ferraz C; Bösenberg E; Drieschner N; Scholz M; Hegedüs L; Paschke R Thyroid; 2014 Feb; 24(2):305-13. PubMed ID: 23837487 [TBL] [Abstract][Full Text] [Related]
33. Thyroid nodules classified as atypia or follicular lesions of undetermined significance deserve further research: Analysis of 305 surgically confirmed nodules. Turkyilmaz S; Ulusahin M; Celebi B; Cekic AB; Mungan S; Kucuktulu U; Tasdelen A; Guner A; Cinel A Cytopathology; 2017 Oct; 28(5):391-399. PubMed ID: 28714532 [TBL] [Abstract][Full Text] [Related]
34. Thyroid cytology in Pakistan: An institutional audit of the atypia of undetermined significance/follicular lesion of undetermined significance category. Fatima S; Qureshi R; Imran S; Idrees R; Ahmad Z; Kayani N; Ahmed A Cytopathology; 2021 Mar; 32(2):205-210. PubMed ID: 33098589 [TBL] [Abstract][Full Text] [Related]
35. The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma? Lei L; Hong Qing S; Wei L; Ma Mo Yang F; Xiao Xiang Y Am Surg; 2024 Dec; 90(12):3209-3215. PubMed ID: 39047144 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy. Bellevicine C; Migliatico I; Sgariglia R; Nacchio M; Vigliar E; Pisapia P; Iaccarino A; Bruzzese D; Fonderico F; Salvatore D; Biondi B; Masone S; Novizio V; Scavuzzo F; Serino D; De Palma M; Chiofalo MG; Botti G; Pezzullo L; Nuzzo V; Spiezia S; De Chiara G; Iorio S; Conzo G; Docimo G; Faggiano A; Bongiovanni M; Malapelle U; Colao A; Triassi M; Troncone G; Cancer Cytopathol; 2020 Feb; 128(2):107-118. PubMed ID: 31821746 [TBL] [Abstract][Full Text] [Related]
37. Subcategorisation of AUS/FLUS thyroid lesions as per the 2017 Bethesda System for Reporting Thyroid Cytopathology: a retrospective study from a tertiary care centre analysing risk of malignancy (ROM) of the different subcategories. Guleria P; Agarwal S; Iyer VK; Jain D; Mathur SR; Yadav D J Clin Pathol; 2019 Nov; 72(11):771-777. PubMed ID: 31375535 [TBL] [Abstract][Full Text] [Related]
38. Follicular lesion of undetermined significance in thyroid FNA revisited. Walts AE; Mirocha J; Bose S Diagn Cytopathol; 2014 Jan; 42(1):18-22. PubMed ID: 23894017 [TBL] [Abstract][Full Text] [Related]
39. Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology. Mehta RS; Carty SE; Ohori NP; Hodak SP; Coyne C; LeBeau SO; Tublin ME; Stang MT; Johnson JT; McCoy KL; Nikiforova MN; Nikiforov YE; Yip L Surgery; 2013 Oct; 154(4):730-6; discussion 736-8. PubMed ID: 24074409 [TBL] [Abstract][Full Text] [Related]
40. Risk of malignancy in Thyroid "Atypia of undetermined significance/Follicular lesion of undetermined significance" and its subcategories - A 5-year experience. Thakur A; Sarin H; Kaur D; Sarin D Indian J Pathol Microbiol; 2019; 62(4):544-548. PubMed ID: 31611437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]